Navigation Links
Multifocal/multicentric breast cancer connected to a patient's risk of local recurrence
Date:10/28/2012

BOSTON, MA (October 28, 2012)Not all women diagnosed with operable breast cancer present with a single tumor; some have multifocal disease appear in the breast, which means multiple tumors found in the same breast quadrant, while others have multicentric disease, where multiple tumors are found in separate breast quadrants. Multifocal or multicentric disease is not a standard indication to receive radiation after mastectomy. For patients who undergo lumpectomy, radiation dose and extent is not altered based on multifocal or multicentric disease compared to patients presenting with a single tumor.

Though previous researchers have analyzed data on patients with this type of breast cancer, "there is not a strong consensus on whether or not having multifocal or multicentric breast cancer leads to higher recurrence rates," says Tiffany Tam, MD, an attending physician in the Radiation Oncology Department at Fox Chase Cancer Center, who will present new findings about this on October 30 at the American Society for Radiation Oncology's 54th Annual Meeting.

Tam led a team of Fox Chase physicians in a retrospective study designed to investigate for possible differences in outcomes. They found no statistically significant difference in overall survival or distant recurrence, where the cancer spreads to other organs or tissues. However, local recurrencehaving cancer return to the same area from which it was surgically removedoccurred more than 2.5 times more often among patients with multifocal/multicentric disease, compared to patients with a single tumor.

Tam and her colleagues analyzed the medical records of 112 women who were treated for multifocal or multicentric breast cancer at Fox Chase between 1983 and 2010. They compared outcomes data from those patients with data from 263 women treated for unifocal disease during the same period. Patients from the two groups were matched by age, gender, and stage at diagnosis. The researchers inc
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Eliminating the good cholesterol receptor may fight breast cancer
2. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Scientists uncover multiple faces of deadly breast cancer
5. Depo-Provera Birth Control Might Raise Breast Cancer Risk
6. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
7. Mayo Clinic launches whole genome breast cancer study
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Teen Drinking May Boost Odds of Precancerous Breast Changes
10. Stress contributes to cognitive declines in women with breast cancer, researcher says
11. Breast Cancer Treatment Side Effects May Last for Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... During 2015-2019, the North American probiotic ... the European and APAC probiotic markets are the dominant ... probiotic market lags behind owing to the certain eating ... North American probiotic market is led by the USA ... and Mexico. The North American market for probiotics is ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 HHT is ... for generations. While it can have seemingly mild ... and catastrophic events. Hereditary Hemorrhagic Telangiectasia (HHT) is ... vessels that lack normal capillary connections between an artery ... cause frequent, severe nosebleeds, but may also be present ...
(Date:5/4/2015)... May 04, 2015 Milton Hershey School® ... 2015 Alumnus of the Year, recognizing his commitment to ... philanthropy he sets for MHS students. , “Dr. Graves ... happen when children are provided a top-notch education, a ... their passions,” said Pete Gurt ’85, president of MHS. ...
(Date:5/4/2015)... 2015 Getting patients to work with ... is critical to achieving the “triple aim” of better ... this will require a shift in thinking from stakeholders ... health systems move beyond their traditional boundaries to reach ... the third live meeting of the ACO and ...
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is set to host its annual ... West Orange, NJ on June 1, 2015. Since 2010, ... programs through LRF. , This year, the Lymphoma Research ...
Breaking Medicine News(10 mins):Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2
... by Stanford University researchers found patients with refractory partial ... after deep brain stimulation. This multi-center clinical trial ... nuclei of thalamus for epilepsy (SANTE) persisted and by ... frequency. Full findings of this study are available ...
... LEESBURG, Va. , March 17 ... issued a warning to the leadership of the U.S. House ... and pass," "self-executing," or "Slaughter Rule" to enact H.R. 3590, ... been previously approved by the Senate. If this tactic is ...
... to Tackle State,s Health Care Crisis & Everything to Make it Worse , ... , , ... ... BOISE, Idaho , March 17 The health ...
... SAN FRANCISCO , March 17 For the last year, SEIU officials have been suing 29 local union reformers and whistleblowers who exposed the union,s corruption and backroom deals ... ... ... ...
... tends to omit them, report finds , WEDNESDAY, March 17 ... medical studies involving issues of sexual health such as impotence ... "Our study indicates that it,s more prevalent than one might ... which appears in the March 18 issue of the ...
... ... for the first time , ... Las Vegas, NV (Vocus) March 17, 2010, , , , ,Calendar Notice, , ,2011 AHR ... , www.ahrexpo.com , , ,WHAT:    ,2011 AHR EXPO® (International Air-Conditioning, Heating, Refrigerating Exposition) , ...
Cached Medicine News:Health News:Deep brain stimulation reduces epileptic seizures in patients with refractory partial and secondarily generalized seizures 2Health News:Deep brain stimulation reduces epileptic seizures in patients with refractory partial and secondarily generalized seizures 3Health News:Landmark Legal Foundation to File Suit to Stop President's Health Plan if 'Slaughter Rule' is Used 2Health News:Gov. Signs Law Putting Politics Before Patients 2Health News:Gov. Signs Law Putting Politics Before Patients 3Health News:Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday 2Health News:Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday 3Health News:Gays, Lesbians Excluded From Some Medical Studies 2Health News:2011 AHR EXPO Calendar Listing 2Health News:2011 AHR EXPO Calendar Listing 3Health News:2011 AHR EXPO Calendar Listing 4
(Date:5/4/2015)... board of directors of Eli Lilly and Company (NYSE: ... of 2015 of $0.50 per share on outstanding common stock. ... to shareholders of record at the close of business on ... is a global healthcare leader that unites caring with discovery ... were founded more than a century ago by a man ...
(Date:5/4/2015)... and TORONTO , May 4, 2015 ... today announced that it intends to dividend to its ... completion of a definitive licensing agreement to license its ... www.smoofi.com ) (OTCQB:SMFI). As announced on April ... intent in respect of the licensing of its RapidMist™ ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, ... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) with ... BAX ) jointly announced that Baxter has submitted ... Medicines Agency (EMA) for MM-398 (irinotecan liposome injection), ... adenocarcinoma of the pancreas who have been previously ...
Breaking Medicine Technology:Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3
... 18, 2012  UCB, a leading biopharmaceutical company committed to ... sponsor multiple sets of key epilepsy data at the ... (AAN) in New Orleans from April 21-28.  The data ... drug (AED) Vimpat® (lacosamide) C-V, including updated health-related quality ...
... 18, 2012  Sotera Wireless, Inc. announced that it has ... Drug Administration (FDA) for the ViSi Mobile™   System, ... in hospitals. The clearance represents a major milestone in ... system, particularly for ambulatory hospital patients. "Continuous ...
Cached Medicine Technology:UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 2UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 3UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 4UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 5UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 6UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 7UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 8UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 9Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System 2
The Vitatron Pirouet S+ lead series are endocardial leads with extendable/retractable helical screw designed for reliable fixation and optimal pacing characteristics....
Used to occupy an empty hole which is not being used in an implantablepacemaker header....
Implantable medical grade silicone sleeve for adapting a 5 mm (01) connector to a 6 mm (02) connector....
Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
Medicine Products: